Back to search
Mucopolysaccharidosis III, Type B (MPS IIIB)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mucopolysaccharidosis III, Type B (MPS IIIB) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Mucopolysaccharidosis III, Type B (MPS IIIB) trials you may qualify forScreenPlus is a consented, multi-disorder pilot newborn screening program implemented in conjunction with the New York State Newborn Screening Program that prov…
This is a Phase 3B/4, multicenter, multinational, open label study to further evaluate intracerebroventricular (ICV) delivered AX 250 treatment in MPS IIIB subj…
The primary objectives of this study are to evaluate the long-term safety and tolerability of AX 250 administered to subjects with MPS IIIB by an implanted ICV…